The role of the HPRT gene in human disease
- PMID: 2875930
The role of the HPRT gene in human disease
Abstract
Human HPRT deficiency leads to two major forms of human disease. Partial enzyme deficiency results in gouty arthritis, while an almost complete deficiency leads to the Lesch-Nyhan disease. The latter is characterized by severe neurological dysfunction in addition to gouty arthritis, including retardation, choreoathetosis and aggressive and compulsive self-mutilation. The biochemical basis for the neurological symptoms is not understood. The human and mouse cDNA (RNA copy) genes have been isolated and sequenced. In addition, the amino acid sequence of the human protein has been directly determined. The human and mouse proteins differ at 7 amino acids out of the total, (including the N terminal methionine, which is processed off during maturation) of 218. There are 42 out of 654 nucleotide differences between the human and mouse genes in the amino acid coding region. The mouse genomic structure has been determined. It has 9 exons and 8 introns with a total size of approximately 36 kb. The human gene is very similar with identical intron-exon junction points and approximately the same total gene size. Both mouse and human presumed promotor region at the 5' end, lack a recognizable promotor in the form of a "TATAA" box and are very G-C rich, though not the same. This may be a feature of most "housekeeping" genes. HPRT gene point mutations in three gouty arthritis and one Lesch-Nyhan patient have been identified by peptide sequencing. Six gross gene rearrangements have been identified in Lesch-Nyhan HPRT genes. However it is likely that most mutations are point mutations or small deletions. So far all gene mutations identified are different from all others. The gene has been engineered into retrovirus vehicles which allows its efficient introduction into a wide variety of cells, including mouse marrow stem cells. This may allow treatment of Lesch-Nyhan patients as a model of gene therapy.
Similar articles
-
Molecular analysis of HPRT deficiencies: an update of the spectrum of Asian mutations with novel mutations.Mol Genet Metab. 2007 Jan;90(1):70-6. doi: 10.1016/j.ymgme.2006.08.013. Epub 2006 Oct 4. Mol Genet Metab. 2007. PMID: 17027311
-
[A Japanese family with Lesch-Nyhan syndrome resulting from a new point mutation in hypoxanthine-guanine phosphoribosyltransferase gene].No To Shinkei. 1997 Nov;49(11):1009-13. No To Shinkei. 1997. PMID: 9396032 Japanese.
-
A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.Nature. 1987 Mar 19-25;326(6110):295-8. doi: 10.1038/326295a0. Nature. 1987. PMID: 3029599
-
[Deficiencies of hypoxanthine guanine phosphoribosyltransferase (HPRT)].Nihon Rinsho. 2008 Apr;66(4):687-93. Nihon Rinsho. 2008. PMID: 18409516 Review. Japanese.
-
[Complete and partial deficiency of HPRT].Nihon Rinsho. 1996 Dec;54(12):3315-20. Nihon Rinsho. 1996. PMID: 8976112 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous